ClinicalTrials.gg
Active, not recruitingNCT07665398Updated Jul 2, 2026

Effect of Marjoram, Vetiver, and Lavender Oil in the Treatment of Bruxism

An interventional study of Aromatherapy with Essential Oil Blend (Lavender, Marjoram, Vetiver) and Carrier Oil (Sesame Oil) in Bruxism, Bruxism, Sleep and Bruxism, Sleep-Related, sponsored by Necmettin Erbakan University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-02.

Primary conditionSleep BruxismRegistry: BruxismReclassifiedWhy we changed it
Registry
Bruxism — the first condition term the registry derived for this study.
ClinicalTrials.gg
Sleep Bruxism
Why
  1. The study's listed conditions name Sleep Bruxism, a narrower term within Bruxism.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Necmettin Erbakan University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Sep 2024, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Female
01

Study summary

The aim of this study was to investigate the possible effects of the use of lavender, marjoram and vetiver oil via inhalation and/or massage application on the treatment of bruxism.

Read the detailed description

Bruxism is a repetitive jaw muscle activity characterized by clenching or grinding of the teeth and/or bracing or thrusting of the mandible. Due to increasing evidence suggesting that it may serve a physiological purpose, bruxism has been defined as jaw muscle activity that may occur during sleep and/or wakefulness.

Various methods have been proposed for the treatment of bruxism. These treatment approaches include pharmacological treatments (such as muscle relaxants and clonazepam), orthopedic treatments (such as stabilization splints and rigid stabilization appliances), needling treatments (including acupuncture, botulinum toxin type A, and dry needling), physical and behavioral approaches (such as relaxation training, stress management, biofeedback, and sleep hygiene instructions), manual treatments including exercises (trigger point therapy, soft tissue techniques, exercises, postural corrections, joint mobilizations, and cervical spine treatment), and other physical therapy modalities (including low-level laser therapy, therapeutic ultrasound, and short-wave diathermy).

Manual therapy, therapeutic exercise, and their combination have been shown to effectively reduce pain and improve mandibular function. Massage therapy, which activates the pain-gate mechanism, is an effective treatment option for pain relief. It also stimulates the parasympathetic nervous system and helps restore muscle length and flexibility. In addition, massage therapy improves local blood circulation and promotes the production of endogenous opioids, leading to relaxing effects and reduced pain perception. These effects are of particular interest in the management of bruxism; however, this treatment approach has not been adequately investigated despite its promising results.

Massage therapy can be combined with aromatherapy, one of the most commonly used complementary therapy methods. Its therapeutic effects are based on stimulation of the olfactory system and absorption of active molecules through the skin. Various studies have investigated the analgesic effects of aromatherapy massage using lavender essential oil. Lavandula angustifolia is a well-known medicinal and aromatic plant with anti-inflammatory and analgesic properties. In addition, it has antiseptic, soothing, circulation-stimulating, and cell-regenerating effects. Lavender oil has been reported to reduce pain in patients with various conditions, including neuropathic pain, rheumatoid arthritis, burns, and cancer-related pain. Apart from lavender oil, marjoram oil may contribute to pain control and anxiety reduction, while vetiver oil is known for its sedative effects. However, the effects of aromatherapy massage using these essential oils have not been adequately investigated in patients with bruxism.

The aim of this study is to evaluate the effects of lavender, marjoram, and vetiver essential oils administered through aromatherapy massage in patients with bruxism. Objective outcomes will be assessed through ultrasonographic evaluation of the masseter muscle, while subjective outcomes will be evaluated using patient-reported questionnaires. The findings of this study may contribute to the development of complementary treatment approaches for the management of bruxism.

02

Conditions studied

  • Bruxism
  • Bruxism, Sleep
  • Bruxism, Sleep-Related

Browse trials for

Keywords

  • bruxism
  • sleep bruxism
  • aromatherapy
  • lavender oil
  • marjoram oil
  • vetiver oil
  • essentials oil
  • masticatory muscle
  • masseter muscle
  • ultrasonography
  • myofascial pain
03

In context

Sleep Bruxism Reclassified

62 studies on the registry are indexed under Sleep Bruxism; 11 are open to participants now.

This study's planned enrollment of 64 is above the median of 39 across 38 interventional studies indexed under Sleep Bruxism.

Browse Sleep Bruxism studies →

Lead sponsor

Necmettin Erbakan University is the lead sponsor of 201 studies on the registry; 48 are open to participants now.

Compared within Sleep Bruxism, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Bruxism. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Patients between 18-25

      • Patients with full dentition including 2nd molars
      • Patients without facial asymmetry
      • Patients without history of sensitivity or allergy to plants
      • Patients without olfactory disorders

Exclusion criteria

Exclusion Criteria:

    • Patients with systemic (asthma history) and/or neuromuscular disease

      • Patients with orofacial pain not caused by bruxism
      • Temporomandibular joint (TMJ) surgery or injection history
      • Use of any medical drug affecting the muscular system
      • Patients with developmental deformity or surgery history in the maxillofacial region (facial trauma history, resection history, etc.)
      • TMJ pathologies (major condylar changes seen on panoramic radiograph)
      • Radiotherapy and/or chemotherapy history
      • Ongoing orthodontic treatment
      • Removable prosthesis use
      • Inflammatory connective tissue diseases
      • Pregnancy
      • Obstructive sleep apnea
      • Local skin infection over the myofascial area
      • Reluctance to take responsibility for the work
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Aromatherapy Group

    Participants receive aromatherapy by inhalation twice daily and extraoral massage once daily throughout the study period. Outcomes are evaluated using ultrasonographic measurements and patient-reported questionnaires.

    Other: Aromatherapy with Essential Oil Blend (Lavender, Marjoram, Vetiver)

  • Placebo comparator
    Control Group

    Participants receive carrier oil (sesame oil) administered through inhalation and extraoral massage following the same protocol as the intervention group. Outcomes are evaluated using ultrasonographic measurements and patient-reported questionnaires.

    Other: Carrier Oil (Sesame Oil)

Interventions

  • OtherAromatherapy with Essential Oil Blend (Lavender, Marjoram, Vetiver)

    Participants receive aromatherapy using a proprietary essential oil blend (Lavender Lavandula angustifolia, Marjoram Origanum majorana, and Vetiver Vetiveria zizanioides; Art De Huile®, formulated by Hülya Kayhan). The blend is administered by inhalation twice daily and extraoral massage once daily throughout the study period.

  • OtherCarrier Oil (Sesame Oil)

    Participants receive carrier oil (sesame oil) administered through inhalation and extraoral massage according to the same protocol used in the intervention group.

06

What researchers measure

Primary outcomes

  1. Change in Masseter Muscle Elasticity

    Assessment of changes in masseter muscle elasticity using shear-wave elastography measured by ultrasonography.

    Time frame: Baseline to Week 4

  2. Change in Masseter Muscle Thickness

    Assessment of changes in masseter muscle thickness measured by ultrasonography.

    Time frame: Baseline to Week 4

Secondary outcomes

  1. Change in Bruxism-Related Symptoms

    Assessment of changes in bruxism-related symptoms (jaw pain, headache, tooth sensitivity, fatigue, and perceived stress/anxiety) using the Visual Analog Scale (VAS). Each symptom is rated from 0 (no symptom) to 10 (worst imaginable symptom). Higher scores indicate more severe symptoms. A study-specific patient-reported questionnaire is also used to document the presence and characteristics of bruxism-related symptoms.

    Time frame: Baseline to Week 4

  2. Patient Satisfaction With Treatment

    Assessment of participant satisfaction with the intervention using a study-specific patient-reported questionnaire. Treatment satisfaction is rated on a 5-point Likert scale ranging from 1 (very dissatisfied) to 5 (very satisfied). Higher scores indicate greater treatment satisfaction.

    Time frame: Week 4

07

Study locations

1 site
08

References and documents

Publications

  • Seifert O, Baerwald C. [Stimulation of the vagus nerve as a therapeutic principle. German Version]. Z Rheumatol. 2023 Aug;82(6):462-471. doi: 10.1007/s00393-023-01390-x. Epub 2023 Jul 25. German. PubMed 37490129 ↗
  • Bennett R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol. 2007 Jun;21(3):427-45. doi: 10.1016/j.berh.2007.02.014. PubMed 17602992 ↗
  • Palinkas M, De Luca Canto G, Rodrigues LA, Bataglion C, Siessere S, Semprini M, Regalo SC. Comparative Capabilities of Clinical Assessment, Diagnostic Criteria, and Polysomnography in Detecting Sleep Bruxism. J Clin Sleep Med. 2015 Nov 15;11(11):1319-25. doi: 10.5664/jcsm.5196. PubMed 26235152 ↗
  • Johnson JR, Rivard RL, Griffin KH, Kolste AK, Joswiak D, Kinney ME, Dusek JA. The effectiveness of nurse-delivered aromatherapy in an acute care setting. Complement Ther Med. 2016 Apr;25:164-9. doi: 10.1016/j.ctim.2016.03.006. Epub 2016 Mar 7. PubMed 27062964 ↗
  • Gok Metin Z, Arikan Donmez A, Izgu N, Ozdemir L, Arslan IE. Aromatherapy Massage for Neuropathic Pain and Quality of Life in Diabetic Patients. J Nurs Scholarsh. 2017 Jul;49(4):379-388. doi: 10.1111/jnu.12300. Epub 2017 Jun 12. PubMed 28605119 ↗
  • Nasiri A, Mahmodi MA, Nobakht Z. Effect of aromatherapy massage with lavender essential oil on pain in patients with osteoarthritis of the knee: A randomized controlled clinical trial. Complement Ther Clin Pract. 2016 Nov;25:75-80. doi: 10.1016/j.ctcp.2016.08.002. Epub 2016 Aug 3. PubMed 27863613 ↗
  • Medlicott MS, Harris SR. A systematic review of the effectiveness of exercise, manual therapy, electrotherapy, relaxation training, and biofeedback in the management of temporomandibular disorder. Phys Ther. 2006 Jul;86(7):955-73. PubMed 16813476 ↗
  • Ariji Y, Nakayama M, Nishiyama W, Ogi N, Sakuma S, Katsumata A, Kurita K, Ariji E. Potential clinical application of masseter and temporal muscle massage treatment using an oral rehabilitation robot in temporomandibular disorder patients with myofascial pain. Cranio. 2015 Oct;33(4):256-62. doi: 10.1080/08869634.2015.1097303. Epub 2015 Dec 29. PubMed 26714800 ↗
  • Capellini VK, de Souza GS, de Faria CR. Massage therapy in the management of myogenic TMD: a pilot study. J Appl Oral Sci. 2006 Jan;14(1):21-6. doi: 10.1590/s1678-77572006000100005. PubMed 19089025 ↗
  • Pessoa DR, Costa DR, Prianti BM, Costa DR, Delpasso CA, Arisawa EALS, Nicolau RA. Association of facial massage, dry needling, and laser therapy in Temporomandibular Disorder: case report. Codas. 2018 Nov 29;30(6):e20170265. doi: 10.1590/2317-1782/20182017265. PubMed 30517267 ↗
  • Armijo-Olivo S, Pitance L, Singh V, Neto F, Thie N, Michelotti A. Effectiveness of Manual Therapy and Therapeutic Exercise for Temporomandibular Disorders: Systematic Review and Meta-Analysis. Phys Ther. 2016 Jan;96(1):9-25. doi: 10.2522/ptj.20140548. Epub 2015 Aug 20. PubMed 26294683 ↗
  • Fernandez-de-las-Penas C, Svensson P. Myofascial Temporomandibular Disorder. Curr Rheumatol Rev. 2016;12(1):40-54. doi: 10.2174/1573397112666151231110947. PubMed 26717949 ↗

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be made publicly available due to participant privacy considerations and institutional data protection policies.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2024 (actual). Primary completion is estimated for Dec 2026, 27 months after the start.

Of 19 interventional studies with no phase under Sleep Bruxism, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 13. This study's planned 27 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2026
First posted
Jun 24, 2026
StartActual
Sep 2, 2024
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jan 31, 2027
Last update
Jul 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07665398
Collaborators
Ankara University, Izmir Katip Celebi University, Bilecik Seyh Edebali Universitesi
Responsible party
SULTAN UZUN (Assistant Prof., Bilecik Seyh Edebali Universitesi) — Principal investigator
First posted
Jun 24, 2026
Start date
Sep 2, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Jul 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion